SK-OV-3 Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Key points about the SK-OV-3 cell line
| Description | SK-OV-3 cells, also known as SKOV3 cells, were derived from the ascitic fluid of a 64-year-old Caucasian female with ovarian cancer, are used in the study of serous cystadenocarcinoma, a subtype of ovarian carcinoma. These cells are known for their resistance to tumor necrosis factor and various cytotoxic drugs, including cisplatin, highlighting the challenges in chemotherapy for ovarian cancer treatment and makes them an excellent model for studying the mechanisms underlying cisplatin resistance and exploring new therapeutic strategies. The antioxidant system, including the thioredoxin antioxidant system (Trx), plays a crucial role in the survival and resistance of SK-OV-3 cells, offering a target for interventions aimed at sensitizing cancer cells to chemotherapy. The use of compounds like quercetin to modulate the antioxidant system and induce apoptosis in SK-OV-3 cells highlights the potential for dietary antioxidants in cancer therapy. In addition to their role in studying drug resistance, SK-OV-3 cells are used to investigate the invasive behavior of ovarian carcinoma cells and the interaction between cancer cells and the tumor microenvironment, including the role of M0 and M2 macrophages in tumor progression. The application of SK-OV-3 cells in cancer research extends to the development of xenograft models and the use of reporter genes, such as firefly-Luc, to monitor tumor growth and metastasis in vivo. Overall, SK-OV-3 cells serve as a critical model for understanding the complexity of ovarian cancer, from the molecular mechanisms driving resistance and estrogen signaling to the interaction between cancer cells and the tumor microenvironment. |
|---|---|
| Organisme | Human |
| Tissu | Ovary |
| Maladie | Serous cystadenocarcinoma |
| Site métastatique | Ascites |
| Synonymes | SKOV-3, SK-OV3, SK.OV.3, SKOV3, Skov3, SKO3 |
Properties of ovarian cancer cell line SKOV3
| Âge | 64 years |
|---|---|
| Genre | Female |
| Origine ethnique | Caucasian |
| Propriétés de croissance | Adherent |
Documentation
| Référence | SK-OV-3 (Cytion catalog number 300342) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_0532 |
Genomics
| Isoenzymes | PGM3, 1, PGM1, 1-2, ES-D, 1, Me-2, 1, AK-1, 1, GLO-1, 1-2, G6PD, B, Phenotype Frequency Product: 0.0311 |
|---|---|
| Tumorigène | Forms moderately well differentiated adenocarcinoma consistent with ovarian primary |
| Caryotype | (P16) hypodiploid to hypotetraploid with dicentrics and large telocentric |
Handling SKOV3 cells
| Milieu de culture | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densité de semis | 1 x 104 cells/cm2 |
| Rétablissement après le dégel | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Genetic profile
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 300342-1420SF | Certificat d'analyse | 23. May. 2025 | 300342 |
| 300342-220425 | Certificat d'analyse | 23. May. 2025 | 300342 |
| 300342-131125 | Certificat d'analyse | 08. Jan. 2026 | 300342 |
-
Related products
Related products
SK-BR-3 CellsOrganisme Human Tissu Breast, mammary gland Maladie Invasive ductal carcinoma 545,10 CAD$*